Sylvia Janetzki

4.3k total citations
57 papers, 2.7k citations indexed

About

Sylvia Janetzki is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sylvia Janetzki has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 26 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Sylvia Janetzki's work include Immunotherapy and Immune Responses (24 papers), T-cell and B-cell Immunology (16 papers) and CAR-T cell therapy research (15 papers). Sylvia Janetzki is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), T-cell and B-cell Immunology (16 papers) and CAR-T cell therapy research (15 papers). Sylvia Janetzki collaborates with scholars based in United States, Germany and Netherlands. Sylvia Janetzki's co-authors include Cedrik M. Britten, Pramod K. Srivastava, Axel Hoos, Guido Ferrari, Josephine H. Cox, Jonathan J. Lewis, Leah Price, Nathalie E. Blachère, Lloyd J. Old and F. Stephen Hodi and has published in prestigious journals such as Blood, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sylvia Janetzki

57 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Janetzki United States 27 1.6k 1.1k 1.0k 353 197 57 2.7k
Isabelle Rooney United States 25 1000 0.6× 1.0k 0.9× 618 0.6× 354 1.0× 149 0.8× 49 2.5k
John C. Castle United States 15 1.5k 0.9× 1.2k 1.1× 1.2k 1.2× 173 0.5× 210 1.1× 21 2.8k
Dieter Kube Germany 30 1.4k 0.9× 794 0.7× 1.1k 1.1× 764 2.2× 191 1.0× 76 3.2k
W. James Cook United States 30 1.2k 0.8× 1.1k 1.0× 589 0.6× 553 1.6× 229 1.2× 77 3.5k
Bernard Maillère France 34 1.8k 1.1× 1.2k 1.1× 601 0.6× 437 1.2× 176 0.9× 141 3.7k
Joëlle Wiels France 32 1.1k 0.7× 1.6k 1.5× 687 0.7× 245 0.7× 321 1.6× 91 3.3k
Christopher Schmidt Australia 33 1.9k 1.2× 1.3k 1.2× 1.5k 1.5× 467 1.3× 183 0.9× 88 3.3k
Volker Teichgräber Switzerland 16 1.8k 1.1× 831 0.8× 649 0.6× 371 1.1× 89 0.5× 27 2.8k
Siquan Sun United States 26 2.5k 1.6× 947 0.9× 545 0.5× 344 1.0× 178 0.9× 43 3.7k
Nicola Ternette United Kingdom 29 945 0.6× 1.6k 1.5× 627 0.6× 340 1.0× 175 0.9× 75 2.4k

Countries citing papers authored by Sylvia Janetzki

Since Specialization
Citations

This map shows the geographic impact of Sylvia Janetzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Janetzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Janetzki more than expected).

Fields of papers citing papers by Sylvia Janetzki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Janetzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Janetzki. The network helps show where Sylvia Janetzki may publish in the future.

Co-authorship network of co-authors of Sylvia Janetzki

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Janetzki. A scholar is included among the top collaborators of Sylvia Janetzki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Janetzki. Sylvia Janetzki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Janetzki, Sylvia. (2024). Important Considerations for ELISpot Validation. Methods in molecular biology. 2768. 1–13. 2 indexed citations
3.
Dobbin, Kevin K., Alessandra Cesano, John Alvarez, et al.. (2016). Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations. Journal for ImmunoTherapy of Cancer. 4(1). 77–77. 78 indexed citations
4.
Attig, Sebastian, Nicole Bidmon, Bernhard Y. Renard, et al.. (2012). Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols. Cancer Immunology Immunotherapy. 62(4). 615–627. 20 indexed citations
5.
Hoos, Axel, Sylvia Janetzki, & Cedrik M. Britten. (2012). Advancing the field of cancer immunotherapy. OncoImmunology. 1(9). 1457–1459. 4 indexed citations
6.
Moodie, Zoe, Leah Price, Sylvia Janetzki, & Cedrik M. Britten. (2011). Response Determination Criteria for ELISPOT: Toward a Standard that Can Be Applied Across Laboratories. Methods in molecular biology. 792. 185–196. 42 indexed citations
7.
Janetzki, Sylvia & Cedrik M. Britten. (2011). The Impact of Harmonization on ELISPOT Assay Performance. Methods in molecular biology. 792. 25–36. 29 indexed citations
8.
Britten, Cedrik M., Sylvia Janetzki, Sjoerd H. van der Burg, et al.. (2010). Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunology Immunotherapy. 60(1). 15–22. 38 indexed citations
9.
Britten, Cedrik M., Sylvia Janetzki, Leah Ben‐Porat, et al.. (2009). Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunology Immunotherapy. 58(10). 1701–1713. 47 indexed citations
10.
Janetzki, Sylvia, Leah Price, Cedrik M. Britten, et al.. (2009). Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells. Cancer Immunology Immunotherapy. 59(4). 609–618. 44 indexed citations
11.
Maki, Robert G., Philip O. Livingston, Jonathan J. Lewis, et al.. (2007). A Phase I Pilot Study of Autologous Heat Shock Protein Vaccine HSPPC-96 in Patients With Resected Pancreatic Adenocarcinoma. Digestive Diseases and Sciences. 52(8). 1964–1972. 74 indexed citations
12.
Janetzki, Sylvia, Katherine S. Panageas, Leah Ben‐Porat, et al.. (2007). Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunology Immunotherapy. 57(3). 303–315. 150 indexed citations
13.
Cox, Josephine H., Guido Ferrari, & Sylvia Janetzki. (2006). Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods. 38(4). 274–282. 79 indexed citations
14.
Dyall, Ruben, Ilhem Messaoudi, Sylvia Janetzki, & Janko Nikolić‐Žugić. (2000). MHC Polymorphism Can Enrich the T Cell Repertoire of the Species by Shifts in Intrathymic Selection. The Journal of Immunology. 164(4). 1695–1698. 27 indexed citations
15.
Janetzki, Sylvia, Ping Song, Vanita Gupta, Jonathan J. Lewis, & Alan N. Houghton. (2000). Insect cells as HLA-restricted antigen-presenting cells for the IFN-γ Elispot assay. Journal of Immunological Methods. 234(1-2). 1–12. 21 indexed citations
16.
Janetzki, Sylvia, et al.. (2000). Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study. International Journal of Cancer. 88(2). 232–238. 195 indexed citations
17.
Lewis, Jonathan J., Sylvia Janetzki, Katherine S. Panageas, et al.. (2000). Evaluation of CD8+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. International Journal of Cancer. 87(3). 391–398. 91 indexed citations
18.
Blachère, Nathalie E., Heiichiro Udono, Sylvia Janetzki, et al.. (1993). Heat Shock Protein Vaccines Against Cancer. Journal of Immunotherapy. 14(4). 352–356. 127 indexed citations
19.
Chester, John, B Thiele, Sylvia Janetzki, et al.. (1989). The promoter structure and complete sequence of the gene encoding the rabbit erythroid cell-specific 15-lipoxygenase. Gene. 84(2). 493–499. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Rooney Breakdown of academic impact, for papers by John C. Castle Breakdown of academic impact, for papers by Dieter Kube Breakdown of academic impact, for papers by W. James Cook Breakdown of academic impact, for papers by Bernard Maillère Breakdown of academic impact, for papers by Joëlle Wiels Breakdown of academic impact, for papers by Christopher Schmidt Breakdown of academic impact, for papers by Volker Teichgräber Breakdown of academic impact, for papers by Siquan Sun Breakdown of academic impact, for papers by Nicola Ternette
Rankless by CCL
2026